Results 101 to 110 of about 386 (142)
Psoriasis: an update on topical and systemic therapies. [PDF]
Aust PrescrChan JJ.
europepmc +1 more source
Some of the next articles are maybe not open access.
Related searches:
Related searches:
Thermodynamic properties of methylprednisolone aceponate
Journal of Chemical Thermodynamics, 2016© 2016 Elsevier LtdIn the present work, temperature dependence of heat capacity of methylprednisolone aceponate has been measured for the first time over the range from 7 K to 346 K by precision adiabatic vacuum calorimetry. Based on the experimental results, the thermodynamic functions of the methylprednisolone aceponate, namely, the heat capacity ...
S S Knyazeva +2 more
exaly +4 more sources
Structural study of polymorphism in methylprednisolone aceponate
Journal of Molecular Structure, 2017Abstract The crystal structures of methylprednisolone aceponate were determined by X-ray diffraction analysis at temperatures 90 K and 150 K: space group P212121, a = 14.8592(2), b = 19.6844(5), c = 26.1626(4) A, Z = 12; R = 0.0598 (T = 90 K); space group P212121, a = 6.57348(14), b = 14.8295(3), c = 26.2214(5) A, Z = 4; R = 0.0518 (T = 150 K ...
S S Knyazeva, A V Knyazev
exaly +2 more sources
Overview of clinical experience with methylprednisolone aceponate
Journal of the European Academy of Dermatology and Venereology, 1994AbstractMethylprednisolone aceponate is a new potent topical corticosteroid. Chemically it is a corticoid diester that rapidly penetrates the skin. It is rapidly metabolised and then conjugated so that although potent, it does not appear to cause serious local or systemic side effects.
exaly +2 more sources
Allergic contact dermatitis to methylprednisolone aceponate in a topical corticosteroid
Australasian Journal of Dermatology, 2004SUMMARY A 42‐year‐old registered nurse presented with a recurrent history of multifactorial hand dermatitis, which had ceased to respond to the topical corticosteroid that she was using. Patch testing revealed strong reactions to both Advantan® Fatty Ointment (Commonwealth Serum Laboratories, Melbourne, Australia), and its active ingredient ...
Rosemary Nixon
exaly +3 more sources
Preclinical evaluation of a new topical corticosteroid methylprednisolone aceponate
Journal of the European Academy of Dermatology and Venereology, 1994AbstractObjective: Preclinical characterization of methylprednisolone aceponate.Results: The local antiinflammatory potency of methylprednisolone aceponate was equal to the very strong glucocorticoid clobetasol 17‐propionate but higher than the potency of hydrocortisone 17‐butyrate after topical application in 2 animal models of inflammation ...
H.J. Zentel, M. Töpert
exaly +2 more sources
Long‐term treatment with 6α‐methylprednisolone aceponate
Journal of the European Academy of Dermatology and Venereology, 1994AbstractAim 6α‐Methylprednisolone aceponate (MPA) is a new steroid double ester for topical use, the potent action and lack of untoward side‐effects of which became evident in two different studies.Background Recent studies have proved the concept that MPA is both potent and extremely well tolerated when used for a relatively short time.Methods Two ...
exaly +2 more sources
Clinical comparison of methylprednisolone aceponate and prednicarbate in chronic eczema
Journal of the European Academy of Dermatology and Venereology, 1994AbstractMethylprednisolone aceponate (MPA) is a new topical corticosteroid developed specifically for the treatment of eczematous disorders. A multicentre, controlled, randomized open trial to assess the efficacy and tolerability of a once daily application of MPA in comparison to a twice‐daily application of Prednicarbate (PC) was conducted in 566 ...
exaly +2 more sources
Segmental lichen aureus: A report of two cases treated with methylprednisolone aceponate
Australasian Journal of Dermatology, 2011Two cases of segmental lichen aureus with a response to topical 0.1% methylprednisolone aceponate ointment are reported. A 9-year-old child and a 23-year-old man showed complete resolution of their lesions following treatment with the latter after 7 months and 4 months, respectively.
John, Moche +3 more
exaly +2 more sources
Contact sensitization to 6 alpha-methylprednisolone aceponate.
American journal of contact dermatitis : official journal of the American Contact Dermatitis Society, 1997Increasing attention has been focused on contact sensitization to topical corticosteroids in the past several years. In most cases, allergy to topical corticosteroids occurs in patients with long-lasting eczematous diseases. Cross-allergy between topical corticosteroid molecules is very common, and four groups of cross-reacting molecules have been ...
Balato N +4 more
openaire +5 more sources